Short answer
STARZ ENTERTAINMENT CORP /CN/ (STRZ) filed an 8-K current report with the SEC on March 11, 2026 reporting Item 3.03 (Material Modification to Rights of Security Holders). Poison pill adopted March 10, 2026: triggers if any shareholder acquires 17.5%+ of outstanding Common Shares.
STARZ ENTERTAINMENT CORP /CN/ 8-K event analysis
AI summary of each reported item and its exhibits
Item 3.03 · Material Modification to Rights of Security Holders
- Poison pill adopted March 10, 2026: triggers if any shareholder acquires 17.5%+ of outstanding Common Shares
- Rights exercise price set at $93.00 per Common Share; upon Flip-in, holders (excluding acquirer) can buy shares at 50% of market price (2x value for 1x price)
- Rights expire March 10, 2027 unless ratified by shareholders, extending to March 10, 2029; board can redeem at $0.001 per Right anytime before Flip-in
- Board retains unilateral power to amend Rights Agreement without shareholder consent pre-trigger: limits shareholder ability to remove this defense
- Clear takeover deterrent: any hostile buyer crossing 17.5% faces massive dilution unless board redeems Rights first, protecting against unsolicited acquisition attempts
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other STARZ ENTERTAINMENT CORP /CN/ 8-K filings
Get the next STRZ 8-K as it lands
Follow STRZ for push alerts, or ask the research agent what this filing means.